Skip to main content

Daunorubicin liposomal

  • Chapter
Paravasation von Zytostatika

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Primärliteratur

  1. Cabriales S, Bresnahan J, Testa D, et al: Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi’s sarcoma: a report of four cases. Oncol Nurs Forum 25: 67–70, 1998.

    PubMed  CAS  Google Scholar 

  2. Guaglianone P, Chan K, Hanisch R, et al: Phase I clinical trial of liposomal daunorubicin (Daunoxome) in advanced malignancies. Proc ASCO 11: 35, 1992.

    Google Scholar 

  3. Sharma D, Muggia F, Lucci L, et al: Liposomal daunorubicin (VS103): tolerance and clinical effects in AIDS-related Kaposi’s sarcoma (KS) during a phase I study. Proc ASCO 9: 4, 1990.

    Google Scholar 

Sekundärliteratur

  1. Stanley A: Managing complications of chemotherapy. In: Allwood M, Stanley A, Wright P (eds) The Cytotoxics Handbook. Radcliffe Medical Press, 3rd edition: 105–124, 1997.

    Google Scholar 

  2. Mullin S, Beckwith MC, Tyler LS: Prevention and management of antineoplastic extravasation injury. Hosp Pharm 35: 57–76, 2000.

    Google Scholar 

  3. van Gemmern R: Gewebstoxizität und Paravasatbehandlung neuer Zytostatika. Krankenhauspharmazie 17: 471–473, 1996.

    Google Scholar 

  4. Bertelli G: Prevention and management of extravasation of cytotoxic drugs. Drug Safety 12: 245–255, 1995.

    Article  PubMed  CAS  Google Scholar 

  5. Schneider G: Paravasate von Zytostatika. Diagnostik und Therapie. Aina S. Schneider Verlag, 6. Auflage: 1–17, 1999.

    Google Scholar 

  6. Dorr RT: Antidotes to vesicant chemotherapy extravasations. Blood Rev 4: 41–60, 1990.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Wien

About this chapter

Cite this chapter

Mader, I., Fürst-Weger, P., Mader, R.M., Semenitz, E.I., Terkola, R., Wassertheurer, S.M. (2002). Daunorubicin liposomal. In: Paravasation von Zytostatika. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3799-4_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-3799-4_20

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-3800-7

  • Online ISBN: 978-3-7091-3799-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics